Evidence map›Paper›PMID 35688320›Full record

ArticleCellular and molecular gastroenterology and hepatology2022

Loss of MMR and TGFBR2 Increases the Susceptibility to Microbiota-Dependent Inflammation-Associated Colon Cancer.

Elena Tosti, Ana S Almeida, Tam T T Tran, Mariel Barbachan E Silva, Pilib Ó Broin, Robert Dubin, Ken Chen, Amanda P Beck, Andrew S Mclellan, Eduardo Vilar and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cellular and molecular gastroenterology and hepatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Elena TostiDepartment of Cell Biology, Albert Einstein College of Medicine, Bronx, New York. Electronic address: elena.tosti@einsteinmed.edu.
Ana S AlmeidaAPC Microbiome Ireland and School of Microbiology, University College Cork, Cork, Ireland.
Tam T T TranUniversity of Science and Technology of Hanoi, Vietnam Academy of Science and Technology, Hanoi, Vietnam.
Mariel Barbachan E SilvaSchool of Mathematics, Statistics and Applied Mathematics, National University of Ireland Galway, Galway, Ireland.
Pilib Ó BroinSchool of Mathematics, Statistics and Applied Mathematics, National University of Ireland Galway, Galway, Ireland.
Robert DubinDepartment of Cell Biology, Albert Einstein College of Medicine, Bronx, New York.
Ken ChenDepartment of Cell Biology, Albert Einstein College of Medicine, Bronx, New York.
Amanda P BeckDepartment of Pathology, Albert Einstein College of Medicine, Bronx, New York.
Andrew S MclellanDepartment of Genetics and Genomic Sciences, Mount Sinai School of Medicine, New York, New York.
Eduardo VilarDepartment of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston, Texas.
Aaron GoldenSchool of Mathematics, Statistics and Applied Mathematics, National University of Ireland Galway, Galway, Ireland.
Paul W O'TooleAPC Microbiome Ireland and School of Microbiology, University College Cork, Cork, Ireland.
Winfried EdelmannDepartment of Cell Biology, Albert Einstein College of Medicine, Bronx, New York. Electronic address: winfried.edelmann@einsteinmed.edu.
Albert Einstein College of Medicine · USOllscoil na Gaillimhe – University of Galway · IEAPC Microbiome Institute · IEHanoi University of Science and Technology · VNIcahn School of Medicine at Mount Sinai · USThe University of Texas MD Anderson Cancer Center · US

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI STEVEN C. ALMO · 1985 to 2026
$111.2M
Genetic and Dietary Interactions in MMR Deficient Colon TumorigenesisR01CA222358 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI AUGENLICHT, LEONARD H, EDELMANN, WINFRIED · 2018 to 2022
$3.2M
Analyzing the Hypersensitivity of MMR-deficient Colorectal Cancers to mTOR Inhibition and the Response of Cancer Stem CellsR01CA248536 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI EDELMANN, WINFRIED · 2021 to 2025
$2.0M
NCI NIH HHS P30 CA013330NCI NIH HHS R01 CA222358NCI NIH HHS R01 CA248536
6 · The paper itself

Abstract

BACKGROUND AND

aimsMutations in DNA mismatch repair (MMR) genes are causative in Lynch syndrome and a significant proportion of sporadic colorectal cancers (CRCs). MMR-deficient (dMMR) CRCs display increased mutation rates, with mutations frequently accumulating at short repetitive DNA sequences throughout the genome (microsatellite instability). The TGFBR2 gene is one of the most frequently mutated genes in dMMR CRCs. Therefore, we generated an animal model to study how the loss of both TGFBR2 signaling impacts dMMR-driven intestinal tumorigenesis in vivo and explore the impact of the gut microbiota.

methodsWe generated VCMsh2/Tgfbr2 mice in which Msh2

resultsVCMsh2/Tgfbr2 mice developed small intestinal adenocarcinomas and CRCs with histopathological features highly similar to CRCs in Lynch syndrome patients. The CRCs in VCMsh2/Tgfbr2 mice were associated with the presence of colitis and displayed genetic and histological features that resembled inflammation-associated CRCs in human patients. The development of CRCs in VCMsh2/Tgfbr2 mice was strongly modulated by the gut microbiota composition, which in turn was impacted by the TGFBR2 status of the tumors.

conclusionsOur results demonstrate a synergistic interaction between MMR and TGFBR2 inactivation in inflammation-associated colon tumorigenesis and highlight the crucial impact of the gut microbiota on modulating the incidence of inflammation-associated CRCs.

Indexed as

Colonic NeoplasmsColorectal Neoplasms, Hereditary NonpolyposisMicrobiotaAnimalsCarcinogenesisDNA Mismatch RepairHumansInflammationMiceReceptor, Transforming Growth Factor-beta Type IIReceptor, Transforming Growth Factor-beta Type IIColon CancerDNA Mismatch RepairGut MicrobiotaInflammation

Identifiers

PMID35688320
PMCPMC9421583
OpenAlexW4281606878

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.